BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21424037)

  • 41. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
    Guan P; Howell-Jones R; Li N; Bruni L; de Sanjosé S; Franceschi S; Clifford GM
    Int J Cancer; 2012 Nov; 131(10):2349-59. PubMed ID: 22323075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Testing for high risk human papilloma virus in the initial follow-up of women treated for high-grade squamous intraepithelial lesions.
    Smart OC; Sykes P; Macnab H; Jennings L
    Aust N Z J Obstet Gynaecol; 2010 Apr; 50(2):164-7. PubMed ID: 20522074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL) and histology.
    Rossetti D; Gerli S; Saab JC; Di Renzo GC
    J Med Liban; 2000; 48(3):127-30. PubMed ID: 11268564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
    Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
    J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
    Nasser SM; Cibas ES; Crum CP; Faquin WC
    Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more.
    Siebers AG; van der Linden H; Vedder JEM; Bekkers RLM; Melchers WLG; Bulten J
    Cytopathology; 2018 Jun; 29(3):275-280. PubMed ID: 29575519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany.
    Remschmidt C; Kaufmann AM; Hagemann I; Vartazarova E; Wichmann O; Deleré Y
    Int J Gynecol Cancer; 2013 Mar; 23(3):519-26. PubMed ID: 23360813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions.
    Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Pawlita M; Arbyn M;
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):406-14. PubMed ID: 23334590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Human papillomavirus genotyping of cervical uterine preneoplastic lesions in a high risk area].
    López M J; Ili G CG; Brebi M P; García M P; Capurro V I; Guzmán G P; Suárez P E; Ojeda F JM; Roa S JC
    Rev Med Chil; 2010 Nov; 138(11):1343-50. PubMed ID: 21279245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial.
    Elfström KM; Smelov V; Johansson AL; Eklund C; Naucler P; Arnheim-Dahlström L; Dillner J
    Int J Cancer; 2015 Jan; 136(2):350-9. PubMed ID: 24842156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion.
    Wu HH; Allen SL; Kirkpatrick JL; Elsheikh TM
    Diagn Cytopathol; 2006 Oct; 34(10):707-10. PubMed ID: 16955480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
    Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cervical squamous intraepithelial lesions and associated cervical infections in an HIV-positive population in Rural Mpumalanga, South Africa.
    Swanepoel PJ; Michelow P; Du Plessis R; Proudfoot IG; Tarr GA; Bockel SL; Swanepoel CJ
    Cytopathology; 2013 Aug; 24(4):264-71. PubMed ID: 22817687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.
    Costa S; De Simone P; Venturoli S; Cricca M; Zerbini ML; Musiani M; Terzano P; Santini D; Cristiani P; Syrjänen S; Syrjänen K
    Gynecol Oncol; 2003 Aug; 90(2):358-65. PubMed ID: 12893200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
    Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
    Capobianco G; Marras V; Wenger JM; Santeufemia DA; Ambrosini G; Lutzoni R; Dessole M; Cherchi PL
    Eur J Gynaecol Oncol; 2013; 34(3):227-30. PubMed ID: 23967551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.
    Lee SJ; Lee AW; Kang CS; Park JS; Park DC; Ki EY; Lee KH; Yoon JH; Hur SY; Kim TJ
    Int J Med Sci; 2014; 11(1):80-6. PubMed ID: 24396289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
    Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
    Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.